Large pharma companies at World ADC London 2027

Mar 8–11, 2027 London, UK ~700 attendees Website

13 large pharma companies are at World ADC London 2027 — 10 presentations on the program. Most represented: AstraZeneca (3 on the program), Johnson & Johnson (2 on the program), Pierre Fabre (2 on the program). 1 of them have their own page in this guide. As of Oct 8, 2026.

All 75 organizations at World ADC London 2027 →

Showing 1–13 of 13 organizations

Organization	World ADC London 2027 Attendance
AstraZeneca Cambridge, UK
astrazeneca.com Large pharma Global pharmaceutical company whose ADCs include trastuzumab deruxtecan and datopotamab deruxtecan, co-developed with Daiichi Sankyo.	Talk A Justified Limit for the Identification Threshold of Organic Impurities in Drug-Linker Intermediates Used to Produce Antibody-Drug Conjugates Process & Analytical Development Manufacturing & supply chain Talk Aseptic Manufacturing of Antibody-Drug Conjugates – From Process Development to Validation Process & Analytical Development Manufacturing & supply chain Talk Wed Mar 10 3:30pm A Scalable Lysine Bioconjugation Platform: Reducing Development Burden as Clinical Demand Scales Plenary Process & analytical developmentManufacturing & supply chain Also Presenting at the meeting, beyond the sessions above
Johnson & Johnson New Brunswick, NJ
jnj.com Large pharma Healthcare company that develops and markets medicines, including cancer therapies, through its Innovative Medicine business.	Talk ADC Regulatory CMC 101: Introducing Core Principles, Guidance & Challenges Facing ADC Drug CMC & Submissions Pre-conference: 3rd Regulatory CMC Day Also Presenting at the meeting, beyond the sessions above
Pierre Fabre Castres, France
pierre-fabre.com Large pharma French pharmaceutical and dermo-cosmetics group developing oncology medicines, including antibody-drug conjugates.	Workshop Thu Mar 11 1:00pm Manufacturing Bispecifics, Dual Payloads & Novel Formats (DACs, AOD, POCs) at Scale Post-conference workshop for Process & Analytical Development Manufacturing & supply chain Also Presenting at the meeting, beyond the sessions above
Roche Basel, Switzerland
roche.com Large pharma Pharmaceutical and diagnostics company developing medicines in oncology, immunology, neuroscience and other areas.	Workshop Thu Mar 11 1:00pm Designing the Next Generation of ADCs: Exploring Novel Constructs & Future Combination Strategies Post-conference workshop for Discovery Clinical development
Amgen Thousand Oaks, CA
amgen.com Large pharma Global biotechnology company with marketed medicines in oncology, inflammation and cardiovascular disease, and research in protein therapeutics.	Talk Wed Mar 10 8:30am Precision Delivery of Therapeutics with Antibodies Through Biology, Chemistry & AI Plenary ADC discovery
Boehringer Ingelheim Ingelheim, Germany
boehringer-ingelheim.com Large pharma Family-owned German pharmaceutical company with human and animal health medicines and an oncology pipeline.	Panel Tue Mar 9 9:30am CEO & ADC Pharma Leaders Think Tank: Solidifying Next Generation ADCs as Standard of Care Therapies Plenary · with Iksuda Therapeutics, Araris Biotech, Oxford BioTherapeutics Clinical development
Innovent Biologics Suzhou, China
innoventbio.com Large pharma Chinese biopharmaceutical company with marketed antibody medicines and a pipeline that includes dual-payload ADCs.	Talk Tue Mar 9 6:00pm Over the Horizon: the Dual Payload Innovation Plenary ADC discovery
Pfizer New York, NY
pfizer.com Large pharma Global pharmaceutical company whose oncology portfolio includes ADCs gained with Seagen, such as PADCEV.	Talk Treating Cancer From the Outside In: The Preclinical & Early Clinical Development of PF-08052667 for Non Muscle Invasive Bladder Cancer Preclinical & Translational Clinical development
AbbVie North Chicago, IL
abbvie.com Large pharma Global pharmaceutical company developing antibody-drug conjugates in oncology, including ABBV-400 for colorectal and other solid tumors.	Also Presenting at the meeting, on no published session yet
BeOne Medicines Basel, Switzerland
beonemedicines.com Large pharma Global oncology company, formerly BeiGene, with marketed medicines including zanubrutinib and tislelizumab.	Also Presenting at the meeting, on no published session yet
Daiichi Sankyo Tokyo, Japan
daiichisankyo.com Large pharma Japanese pharmaceutical company behind the DXd ADC platform, including trastuzumab deruxtecan and datopotamab deruxtecan.	Also Presenting at the meeting, on no published session yet
Merck & Co. Rahway, NJ
merck.com Large pharma Global pharmaceutical company, known as MSD outside the US and Canada, with marketed cancer medicines and an ADC pipeline.	Also Presenting at the meeting, on no published session yet
Taiho Oncology Princeton, NJ
taihooncology.com Large pharma US oncology arm of Japan's Taiho Pharmaceutical, part of Otsuka, developing and selling cancer treatments.	Also Presenting at the meeting, on no published session yet